Cognos Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10604 S La Cienega Blvd, Inglewood, Cali...Phone Number
(310) 641-2700Website
www.cognosthx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Cognos Therapeutics
Cognos Therapeutics, Inc. is a pioneering company focused on developing and commercializing innovative medical products that integrate diagnostic, therapeutic, and sensing technologies with advanced drug delivery systems. Their flagship product, the SINNAIS implantable smart pump, utilizes AI and blockchain to provide precise and controlled delivery of therapeutics, particularly targeting neurological conditions like Alzheimer's and various cancers. With a significant global patient base and a strong emphasis on addressing unmet medical needs, Cognos aims to reshape the standards of care in neurological and oncological health. The company is positioned to capture substantial market opportunities, particularly in the U.S. treatment landscape for Alzheimer's and central nervous system cancers.Explore more
Cognos Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cognos Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cognos Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Cognos Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cognos Therapeutics
Website visits: Recent activity has been detected on your website
Cognos Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cognos Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Cognos Therapeutics launches new products
Check out if Cognos Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cognos Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cognos Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Cognos Therapeutics
Compare insights from companies similar to Cognos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cognos Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cognos Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cognos Therapeutics.
Cognos Therapeutics financials insights
Gather financial insights about Cognos Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Debt
$250K
Cognos Therapeutics Tech Stack
A closer look at the technologies used by Cognos Therapeutics
Cognos Therapeutics News & Media
Cognos Therapeutics Announces Formation of Industry Advisory Board
Mark Webster Appointed Co-Chair of Advisory Board Mark Webster Appointed Co-Chair of Advisory BoardCognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
INGLEWOOD, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Cognos Therapeutics Corp. (“Cognos”, the Company”), an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, announces today that it has signed a Letter of Engagement to retain Maxim Group LLC (“Maxim”) to provide financial advisory and investment banking services, including to assist in identifying and evaluating targeted M&A opportDr. Susan Alpert, MD., PhD, Joins Implantable Device Manufacturer Cognos Therapeutics as Lead Regulatory Consultant
LOS ANGELES, April 2, 2019 /PRNewswire/ -- Dr. Susan Alpert, MD, Ph.D., has been named Lead Regulatory Consultant for Cognos Therapeutics Inc., an implantable device manufacturer that is developing the Sinnais platform, a metronomic infusion pump system with an initial focus on...
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Cognos Therapeutics
Sign Up For FreeTo access detailed company insights
Cognos Therapeutics, Inc. is a pioneering company focused on developing and commercializing innovative medical products that integrate diagnostic, therapeutic, and sensing technologies with advanced drug delivery systems. Their flagship product, the SINNAIS implantable smart pump, utilizes AI and blockchain to provide precise and controlled deliver... Read More
